Conolidine’s analgesic consequences stem from its conversation with non-opioid pain pathways. Compared with opioids, which bind to µ-opioid receptors inside the central nervous system, conolidine modulates alternate molecular targets. A Science Advances research observed that conolidine interacts Using the atypical chemokine receptor ACKR3/CXCR7… Read More

Conolidine’s analgesic effects stem from its conversation with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors while in the central anxious program, conolidine modulates alternate molecular targets. A Science Innovations study located that conolidine interacts Along with the atypical chemokine receptor ACKR3/CX… Read More